Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CSE/ASEP stock hub

CSE/ASEP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/ASEPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/ASEP

In the news

Latest news · CSE/ASEP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-88

P25 -121.5P50 -40.9P75 0.5

ROIC-10.3

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/ASEP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

153

Groups with data

Currency

CAD

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	6
Employees Change	-1%
Employees Change Percent	-14.29
Enterprise value	CAD 5.8M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA04368A2048
Last refreshed	2026-05-10
Market cap	CAD 1.4M
Price	CAD 0.13
Price currency	CAD
Rev Per Employee	49,462.17x
Sector	Healthcare
Sic	3841
Symbol	cse/ASEP
Website	https://asepmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-541.91%
EV Earnings	-0.74x
EV/Sales	19.42x
P/B ratio	0.15x
P/S ratio	4.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	CAD 296,773
Gross Profit Growth	21.67%
Gross Profit Growth Q	0%
Net Income	CAD -7.8M
Net Income Growth Quarters	3%
Pretax Margin	-4,340.01%
Profit Per Employee	CAD -1.3M
ROA	-8.22
Roa5y	-60.88
ROCE	-22.29
ROE	-88.01
ROIC	-10.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-74.02%
Cagr3y	-57.55%
EPS Growth Quarters	3
Revenue Growth	21.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.02
Assets	CAD 13.5M
Cash	CAD 718,220
Current Assets	CAD 732,970
Current Liabilities	CAD 2.3M
Debt	CAD 727,039
Debt Equity	CAD 0.08
Equity	CAD 9.4M
Interest Coverage	-238.8
Liabilities	CAD 4.1M
Long Term Assets	CAD 12.7M
Long Term Liabilities	CAD 1.8M
Net Cash	CAD -8,819
Net Cash By Market Cap	CAD -0.61
Net Debt Equity	CAD 0
Tangible Book Value	CAD -6.2M
Tangible Book Value Per Share	CAD -0.56
WACC	-3.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.32
Net Working Capital	CAD -1.6M
Quick ratio	0.32
Working Capital	CAD -1.6M
Working Capital Turnover	CAD -0.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-28.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-74%
200-day SMA	0.84
3Y total return	-92.35%
50-day SMA	0.3
50-day SMA vs 200-day SMA	50under200
All Time High	10.3
All Time High Change	-98.74%
All Time High Date	2021-11-24
All Time Low	0.09
All Time Low Change	44.44%
All Time Low Date	2026-01-07
ATR	0.03
Beta	-1.74
Beta1y	-1.93
Beta2y	-1.42
Ch YTD	-53.57
High	0.27
High52	0.5
High52 Date	2025-12-18
High52ch	-74%
Low	0.13
Low52	0.09
Low52 Date	2026-01-07
Low52ch	44.44%
Ma50ch	-57.21%
Price vs 200-day SMA	-84.61%
RSI	33.37
RSI Monthly	32.7
RSI Weekly	38.83
Sharpe ratio	0.94x
Sortino ratio	1.72
Total Return	-28.42%
Tr YTD	-53.57
Tr1m	-58.06%
Tr3m	-51.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -2.5M
Operating margin	-837.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,880,597%
Net Borrowing	423,609
Shares Insiders	69.7%
Shares Out	11,123,729
Shares Qo Q	2.17%
Shares Yo Y	28.42%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	13,267.3x
Bv Per Share	0.46
Ch1m	-58.06
Ch1y	-74
Ch3m	-51.85
Ch3y	-92.35
Ch6m	-74
Change	-58.06%
Change From Open	-51.85
Close	0.31
Days Gap	-12.9
Depreciation Amortization	837,104
Dollar Volume	2,080
Earnings Date	2026-05-15
EBIT	CAD -2.5M
EBITDA	CAD -1.6M
EPS	CAD -0.83
F Score	3
Financing CF	423,609
Fiscal Year End	December
Founded	2,021
Investing CF	949,373
Is Primary Listing	1
Last Earnings Date	2025-11-28
Last Report Date	2025-09-30
Last Split Date	2025-04-17
Last Split Type	Reverse
Ma150	0.62
Ma150ch	-78.88%
Ma20	0.26
Ma20ch	-49.9%
Net CF	498,343
Next Earnings Date	2026-05-15
Open	0.27
Position In Range	3.45
Ppne	14,310
Price Date	2026-05-06
Relative Volume	1.21x
Revenue	296,773x
SBC By Revenue	16.1x
Share Based Comp	47,779
Tr6m	-74%
Volume	16,000
Z Score	-2.63

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/ASEP pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/ASEP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/ASEP?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+69.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+28.4%

Negative means the company is buying back shares.

Technical

CSE/ASEP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.4

Neutral momentum band

Price vs 200-day MA

-84.6%

50/200-day relationship not available

Beta (5Y)

-1.74

Less volatile than the market

Sharpe ratio

0.94

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/ASEP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/ASEP stock rating?

cse/ASEP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/ASEP analysis?

The full report lives at /stocks/cse/ASEP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/ASEP?

The latest report frames cse/ASEP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/ASEP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.